Clinical trials
Age clinical trials
Below are recruiting age clinical trials, each written for real people, not researchers. We’re tracking 1,309 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05844449Enrolling by invitationPhase 3
Check long-term safety and effectiveness of CF medicines
This Phase 3 study looks at how well and how safely Vanzacaftor/Tezacaftor/Deutivacaftor works over the long term in people with cystic fibrosis who already took the study medicine before. It may help confirm the best long-term plan and spot important safety issues.
Orange, CaliforniaAges 1 year+ - NCT05735483Enrolling by invitationPhase 3
Long-term lebrikizumab study for moderate to severe eczema
This Phase 3 trial studies whether lebrikizumab is safe and continues to work over the long term for children and teens with moderate-to-severe atopic dermatitis (eczema). It’s meant for people who already finished a related earlier study and can safely continue.
Birmingham, AlabamaAges 6 months–18 years - NCT05687578Enrolling by invitation
Check how a new safety approach works in adults
This study looks at how a new method (PUER) can identify and track previously unrecognized health risks. It may help improve how clinicians spot problems earlier, even in people with or without medical histories.
Atlanta, GeorgiaAges 18–90 - NCT05554692Enrolling by invitation
Study how aging and cochlear implants affect speech timing
This study looks at how the brain processes the timing of sounds and speech in people with cochlear implants and in people with typical hearing. It may help researchers understand what changes with age and how implant hearing works in the real world.
College Park, MarylandAges 18–85 - NCT05539378Enrolling by invitation
Study how sleep affects the brain’s self-cleaning process
This study looks at whether improving or tracking sleep changes how the brain “clears” waste. It may help researchers understand sleep’s role in brain health and how to support it.
ZurichAges 50–80 - NCT05346016Enrolling by invitation
Study of family gut bacteria passed between relatives
This study looks at whether gut bacteria are shared and stay stable within families over generations. If you’re part of the PEARL study family in England, you may be invited to share samples so researchers can understand how these bacteria move through households.
Norwich, NorfolkAges Any age - NCT05307666Enrolling by invitationPhase 4
Older adults using many medications may get simpler care
This study looks at whether older adults do better when their medication plan is simplified. You may be able to join if you’re at least 80, live in the community, and take 6 or more regular oral medications.
Edmonton, AlbertaAges 80 years+ - NCT05127954Enrolling by invitationPhase 3
Long-term migraine tablet study for kids and teens ages 6–17
This study follows kids and teens who already took part in an earlier migraine medication study to check long-term safety and comfort with oral ubrogepant tablets. It may help families understand whether this migraine tablet is safe to keep using over time.
Huntsville, AlabamaAges 6–17 - NCT05015686Enrolling by invitationPhase 3
Live chickenpox vaccine safety study for healthy teens and adults
This trial tests how safe and how well a live, weakened chickenpox (varicella) vaccine works in healthy people age 13 and older. If you qualify, you may receive the study vaccine and be monitored for side effects and immune response.
Shangqiu, HenanAges 13 years+ - NCT04098640Enrolling by invitation
Testing tumor DNA in younger people with metastatic breast cancer
This study looks at your tumor’s molecular (DNA/biologic) features to better understand metastatic breast cancer in people under 50. You may help researchers by providing tissue samples (biopsies) for lab testing.
Seoul, SeoulAges 19–50 - NCT03999801Enrolling by invitationPhase 2
Long-term follow-up for a subretinal eye treatment
This study checks how well a previous eye treatment (RGX-314) lasts over time. There is also an extra “other eye” study for people with age-related macular degeneration affecting both eyes.
Phoenix, ArizonaAges 50 years+ - NCT03825120Enrolling by invitation
Study following ovarian aging and heart risk
This study follows people who were already enrolled in the original OVA study, to track how ovarian aging may affect long-term heart health. It can help doctors understand which risks change over time and why.
San Francisco, CaliforniaAges 35–55 - NCT03395509Enrolling by invitation
Free screening program for diabetes and heart risks
This study looks at how well and how cost-effective a combined health screening is for diabetes and cardiovascular (heart and blood vessel) risks. You may be invited to attend screening around your 67th birthday.
ViborgAges 67–67
Hear when a new Age trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for age?
- Yes. Clin2 currently lists 1,309 recruiting age studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a age trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a age trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.